Latest United States News

Amaero Ltd’s Federal Court-approved re-domiciliation schemes take effect on 11 June 2026, halting ASX trading of existing shares and paving the way for new US HoldCo CDIs to list.

Felix Gold has created Frontier Antimony Refinery Corp., a US-focused refining platform with secured access to military-grade antimony ore from its Treasure Creek Project in Alaska, aiming to address critical supply gaps.

Imricor Medical Systems has submitted the third of four Premarket Approval modules to the FDA, marking a key step towards US approval of its MR-guided cardiac ablation devices.

Meteoric Resources has reported exceptional pilot plant performance at its Caldeira Rare Earth Project in Brazil, achieving magnet rare earth oxide recoveries of 80% in May and exceeding pre-feasibility study targets.

Amaero Ltd has obtained Federal Court approval to re-domicile to Delaware via schemes exchanging Australian shares and options for US HoldCo equivalents, marking a major structural shift.

Spenda Limited has secured $1.85 million from its institutional entitlement offer at $0.004 per share, progressing its $8.545 million capital raise aimed at debt reduction and product development. The retail component opens next week to raise an additional $6.7 million.

Almonty Industries has closed a US$700 million convertible senior notes offering, including a full US$100 million over-allotment exercise, bolstering its balance sheet to accelerate development of the Sangdong tungsten mine and secure a non-China supply chain for Western defence.

Critical Resources has identified 14 pegmatite bodies, including six new ones, at its Mavis Lake Lithium Project, setting the stage for targeted drilling in 2026 as part of its multi-deposit lithium district strategy.

Chariot Resources, through its U.S. subsidiary FMS Lithium Corporation, has significantly expanded its lithium tenure at the Resurgent project in the McDermitt Caldera, staking 573 new claims and nearly doubling its footprint amid improving lithium market conditions.

LTR Pharma has secured a binding US telehealth commercialisation framework for its intranasal erectile dysfunction treatment ROXUS, committing to at least 150,000 prescriptions in the first year and granting exclusivity to Shed Holdings' platform.

GCM Corporation is seeking shareholder approval for a 15-to-1 share consolidation as a strategic step towards a potential listing on a US national stock exchange, aiming to boost international capital access and market visibility.

Amaero Ltd secured strong shareholder approval for its US re-domiciliation schemes and a director option grant at virtual meetings held on 5 June 2026.